Anne M. Fagan
Publications by Year
Research Areas
Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, Health, Environment, Cognitive Aging, Advanced Neuroimaging Techniques and Applications
Most-Cited Works
- → Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease(2011)7,021 cited
- → Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease(2012)3,754 cited
- → Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction(2019)1,647 cited
- → Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia(2015)1,591 cited
- → Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans(2005)1,247 cited
- → APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline(2020)1,208 cited
- → Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance(2011)1,172 cited
- → Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease(2000)936 cited
- → Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease(2019)926 cited
- → Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults(2007)902 cited